Navidea Biopharmaceuticals Inc 's

• NAVB's Stock Performance relative to its Competitors

Aprea Therapeutics Inc Share Performance +25.48% 30 Days

Aprea Therapeutics Inc Profile Aprea Therapeutics Inc is a biopharmaceutical company with a business model focused on developing and commercializing innovative cancer therapies. They aim to leverage their proprietary discovery platform to identify and develop small molecules that selectively target and restore the tumor suppressor protein p53. Their business strategy includes conducting clinical trials, seeking regulatory approvals, and partnering with other organizations for commercialization and distribution. More about Aprea Therapeutics Inc 's Market Share

T2 Biosystems Inc Share Performance -95.87% One Year

T2 Biosystems Inc Profile T2 Biosystems Inc operates on a business model centered around developing and commercializing innovative diagnostic solutions for medical purposes. Their technology relies on magnetic resonance for the detection of pathogens, toxins, and other molecules associated with various diseases. By offering rapid, accurate, and portable diagnostic capabilities, T2 Biosystems aims to improve patient outcomes and facilitate appropriate treatment decisions in healthcare settings. More about T2 Biosystems Inc 's Market Share

Sources: Navidea Biopharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 4, 2026 10:00 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Navidea Biopharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.